Primary Care Provider Adherence to ADA Guidelines for Microalbuminuria Screening

Abstract

Chronic kidney disease (CKD) is on the rise, and its leading cause is diabetes. The American Diabetes Association (2015) estimates that 1.4 million Americans will be newly diagnosed with diabetes each year. Evidence shows that early detection and management of CKD can slow the progression of renal failure, improve quality of life, increase longevity, and reduce healthcare costs. Numerous national guidelines have been created to assist in the prevention of declining kidney function in patients with diabetes through early microalbuminuria screening. However, according to research, primary care providers are not adhering to these guidelines.